Dipartimento di Farmacia (DIFAR), Università di Genova, Genoa, Italy.
Computational Biology Unit, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy.
J Cell Biochem. 2022 Aug;123(8):1281-1284. doi: 10.1002/jcb.30306. Epub 2022 Jul 15.
COVID-19 has been proposed to be an endothelial disease, as endothelial damage and oxidative stress contribute to its systemic inflammatory and thrombotic events. Polyphenols, natural antioxidant compounds appear as promising agents to prevent and treat COVID-19. Polyphenols bind and inhibit the F F -ATP synthase rotary catalysis. An early target of polyphenols may be the ectopic F F -ATP synthase expressed on the endothelial plasma membrane. Among the pleiotropic beneficial action of polyphenols in COVID-19, modulation of the ecto-F F -ATP synthase, lowering the oxidative stress produced by the electron transfer chain coupled to it, would not be negligible.
COVID-19 被认为是一种血管内皮疾病,因为内皮损伤和氧化应激会导致全身性炎症和血栓形成事件。多酚是一种天然抗氧化化合物,似乎是预防和治疗 COVID-19 的有前途的药物。多酚与 F F -ATP 合酶结合并抑制其旋转催化。多酚的早期靶标可能是表达在内皮质膜上的异位 F F -ATP 合酶。在多酚对 COVID-19 的多种有益作用中,调节质膜外侧 F F -ATP 合酶,降低与其偶联的电子传递链产生的氧化应激,作用不可忽视。